← CONOCOPHILLIPS
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $23.7b | $29.1b | $36.4b | $32.6b | $18.8b | $45.8b | $61.0b | $56.7b | $54.9b | $59.0b | |
| Total revenues and other income | — | — | — | — | $19.3b | $48.3b | $82.2b | $58.6b | $57.0b | $61.5b | |
| Cost of Revenue | $10.2b | $12.5b | $14.3b | $11.8b | $8.1b | $18.2b | $34.0b | $22.0b | $20.0b | $22.3b | |
| Gross Profit (Calculated) | $13.5b | $16.6b | $22.1b | $20.7b | $10.7b | $27.7b | $27.1b | $26.5b | $29.4b | $29.5b | |
| Operating expenses: | |||||||||||
| Operating Costs and Expenses | $5.7b | $5.2b | $5.2b | $5.3b | $4.3b | $5.7b | $7.0b | $7.7b | $8.8b | $10.3b | |
| Production and operating expenses | $5.7b | $5.2b | $5.2b | $5.3b | $4.3b | $5.7b | $7.0b | $7.7b | $8.8b | $10.3b | |
| Additional Financial Items | |||||||||||
| Accretion on discounted liabilities | $425.0m | $362.0m | $353.0m | $326.0m | $252.0m | $242.0m | $250.0m | $283.0m | $325.0m | $378.0m | |
| Basic (in shares) | $1.2m | $1.2m | $1.2m | $1.1m | $1.1m | $1.3m | $1.3b | $1.2b | $1.2b | $1.3b | |
| Depreciation, depletion and amortization | $9.1b | $6.8b | $6.0b | $6.1b | $5.5b | $7.2b | $7.5b | $8.3b | $9.6b | $11.5b | |
| Diluted (in shares) | $1.2m | $1.2m | $1.2m | $1.1m | $1.1m | $1.3m | $1.3b | $1.2b | $1.2b | $1.3b | |
| Equity in earnings of affiliates | $52.0m | $772.0m | $1.1b | $779.0m | $432.0m | $832.0m | $2.1b | $1.7b | $1.7b | $1.3b | |
| Foreign Currency Transaction Gain (Loss), before Tax | $19.0m | ($35.0m) | $17.0m | ($66.0m) | $72.0m | $22.0m | $100.0m | ($92.0m) | $50.0m | ($11.0m) | |
| Foreign currency transaction (gain) loss | ($19.0m) | $35.0m | ($17.0m) | $66.0m | ($72.0m) | ($22.0m) | ($100.0m) | $92.0m | ($50.0m) | $11.0m | |
| Gain (loss) on dispositions | $360.0m | $2.2b | $1.1b | $2.0b | $549.0m | $486.0m | $1.1b | $228.0m | $51.0m | $731.0m | |
| Impairments | $139.0m | $6.6b | $27.0m | $405.0m | $813.0m | $674.0m | ($12.0m) | $14.0m | $80.0m | $26.0m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $5.5b | ($5.2b) | $2.9b | $4.7b | ($3.6b) | $8.0b | $16.7b | $9.5b | $6.7b | $6.2b | |
| Income (Loss) from Continuing Operations, Per Basic Share | ($3) | $1 | $5 | $6 | ($3) | $6 | $15 | $9 | $8 | $6 | |
| Income (Loss) from Continuing Operations, Per Diluted Share | ($3) | $1 | $5 | $6 | ($3) | $6 | $15 | $9 | $8 | $6 | |
| Income (Loss) from Equity Method Investments | $52.0m | $772.0m | $1.1b | $779.0m | $432.0m | $832.0m | $2.1b | $1.7b | $1.7b | $1.3b | |
| Income (loss) before income taxes | ($5.5b) | ($2.6b) | $10.0b | $9.5b | ($3.1b) | $12.7b | $28.2b | $16.3b | $13.7b | $12.7b | |
| Income tax provision (benefit) | ($2.0b) | ($1.8b) | $3.7b | $2.3b | ($485.0m) | $4.6b | $9.5b | $5.3b | $4.4b | $4.7b | |
| Investment Income, Interest | $57.0m | $112.0m | $97.0m | $166.0m | $100.0m | $33.0m | $195.0m | $412.0m | $402.0m | $311.0m | |
| Other income | $255.0m | — | — | $1.4b | ($509.0m) | $1.2b | $504.0m | $485.0m | $452.0m | $538.0m | |
| Purchased commodities | $10.0b | $12.5b | $14.3b | $11.8b | $8.1b | $18.2b | $34.0b | $22.0b | $20.0b | $22.3b | |
| Taxes other than income taxes | $739.0m | $809.0m | $1.0b | $953.0m | $754.0m | $1.6b | $3.4b | $2.1b | $2.1b | $2.1b | |
| Taxes, Miscellaneous | $739.0m | $809.0m | $1.0b | $953.0m | $754.0m | $1.6b | $3.4b | $2.1b | $2.1b | $2.1b | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $5.5b | ($2.6b) | $10.0b | $9.5b | ($3.1b) | $12.7b | $28.2b | $16.3b | $13.7b | $12.7b | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | ($3.6b) | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | ($3.6b) | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | $0 | — | — | — | — | — | — | — | — | — | |
| Net Income (Loss) Attributable to Parent | ($3.6b) | ($855.0m) | $6.3b | $7.2b | ($2.7b) | $8.1b | $18.7b | $11.0b | $9.2b | $8.0b | |
| Net Income (Loss) Available to Common Stockholders, Basic | ($3.6b) | ($855.0m) | $6.3b | $7.2b | ($2.7b) | $8.1b | $18.6b | $10.9b | $9.2b | $8.0b | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $56.0m | $62.0m | $48.0m | $68.0m | $46.0m | $0 | $0 | — | — | — | |
| Common Stock, Dividends, Per Share, Declared | $1.00 | $1.06 | $5.36 | $6.43 | ($2.51) | $1.75 | $1.89 | $2.11 | $2.52 | $3.18 | |
| Earnings Per Share, Basic | ($2.91) | ($0.70) | $5.36 | $6.43 | ($2.51) | $6.09 | $14.62 | $9.08 | $7.82 | $6.36 | |
| Earnings Per Share, Diluted | ($2.91) | ($0.70) | $5.32 | $6.40 | ($2.51) | $6.07 | $14.57 | $9.06 | $7.81 | $6.35 | |
| Weighted Average Number of Shares Outstanding, Basic | 1.2m | 1.2m | 1.2m | 1.1m | 1.1m | 1.3m | 1.3b | 1.2b | 1.2b | 1.3b | |
| Weighted Average Number of Shares Outstanding, Diluted | 1.2m | 1.2m | 1.2m | 1.1m | 1.1m | 1.3m | 1.3b | 1.2b | 1.2b | 1.3b | |
| Accretion Expense, Including Asset Retirement Obligations | $425.0m | $362.0m | $353.0m | $326.0m | $252.0m | $242.0m | $250.0m | $283.0m | $325.0m | $378.0m | |
| Exploration expenses | $1.9b | $938.0m | $369.0m | $743.0m | $1.5b | $344.0m | $564.0m | $398.0m | $355.0m | $407.0m | |
| Interest Expense, Debt | $1.3b | $1.1b | $838.0m | $799.0m | $788.0m | $887.0m | $791.0m | $824.0m | $941.0m | $1.2b | |
| Interest and debt expense | $1.2b | $1.1b | $735.0m | $778.0m | $806.0m | $884.0m | $805.0m | $780.0m | $783.0m | $855.0m | |
| Operating Lease, Expense | — | — | — | $341.0m | $321.0m | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | — | $529.0m | $173.0m | $1.4b | ($509.0m) | $1.2b | $47.0m | ($2.0m) | ($181.0m) | ($20.0m) | |
| Other expenses | $255.0m | $529.0m | $173.0m | $1.4b | $13.0m | $102.0m | ($47.0m) | $2.0m | $181.0m | $20.0m | |
| Research and Development Expense | $116.0m | $100.0m | $78.0m | $82.0m | $75.0m | $62.0m | $71.0m | $81.0m | $81.0m | $78.0m | |
| Selling, General and Administrative Expense | $723.0m | $561.0m | $401.0m | $556.0m | $430.0m | $719.0m | $623.0m | $705.0m | $1.2b | $893.0m | |
| Selling, general and administrative expenses | $723.0m | $561.0m | $401.0m | $556.0m | $430.0m | $719.0m | $623.0m | $705.0m | $1.2b | $893.0m | |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement | $202.0m | — | — | — | — | ($102.0m) | ($37.0m) | ($6.0m) | — | ($5.0m) | |
| Income Tax Expense (Benefit) | ($2.0b) | ($1.8b) | $3.7b | $2.3b | ($485.0m) | $4.6b | $9.5b | $5.3b | $4.4b | $4.7b | |
| Other Operating Income (Expense), Net | $255.0m | — | — | $1.4b | ($509.0m) | $1.2b | $504.0m | $485.0m | $452.0m | $538.0m | |
| Total costs and expenses | $29.9b | $35.2b | $28.8b | $27.1b | $22.4b | $35.6b | $53.9b | $42.3b | $43.3b | $48.9b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.